GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
Compound class:
Synthetic organic
Comment: LLP019 is a PROTAC degrader that targets the 3CL (main) protease (Mpro) of SARS-CoV-2 [1]. It is a heterobifunctional molecule that carries a pelitinib-derived warhead to bind an allosteric site of Mpro, linked to 4-hydroxy-thalidomide to engage the cereblon (CRBN) E3 ubiquitin ligase. LLP019 was designed to allow exploration of the anti-viral potential of selective Mpro degradation.
|
|
References |
1. Veeck C, Laube L, Werner A, Diederich W, Becker S. (2025)
Discovery of an Antiviral PROTAC Targeting the SARS-1 CoV-2 Main Protease Using an Allosteric Warhead. BioRxiv, Preprint. DOI: 10.1101/2025.05.03.652023 |